Frequently asked questions
What qualifies as a failure to diagnose cancer in New York?
A failure to diagnose claim arises when a doctor departs from the accepted standard of care by missing, misreading, or delaying a cancer diagnosis that a competent physician would have caught. Common examples include ignoring suspicious imaging, failing to order a biopsy, or dismissing reported symptoms. The delayed diagnosis must have worsened your prognosis or required more aggressive treatment than would have been necessary with timely detection.
How long do I have to file a failure to diagnose cancer lawsuit in New York?
New York medical malpractice claims are governed by CPLR §214-a, which sets a 2.5-year statute of limitations. The clock generally starts from the date of the negligent act or the end of continuous treatment by the same provider for the same condition. The discovery rule is narrow in NY, so if you recently learned your cancer was missed years ago, consult an attorney immediately to determine whether your claim is still timely.
What do I need to prove in a NY failure to diagnose cancer case?
You must establish four elements: (1) a doctor-patient relationship existed; (2) the physician departed from the accepted standard of medical care; (3) that departure directly caused a delay in diagnosis; and (4) the delay caused you quantifiable harm, such as a worse cancer stage, more invasive treatment, or reduced survival odds. New York requires an expert medical affidavit of merit to initiate a malpractice case, so securing a qualified oncology or pathology expert early is critical.
What types of cancer are most often involved in missed-diagnosis lawsuits?
Breast, colon, lung, cervical, and skin (melanoma) cancers are among the most commonly litigated failure-to-diagnose cases in New York because they have established screening protocols that, when ignored, can lead to clear departures from the standard of care. Prostate and pancreatic cancer cases also arise frequently. Any cancer where earlier detection would have materially changed treatment options or survival outcomes can form the basis of a valid claim.